CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 4, 2022 · earnings

DMAC earnings: a negative outcome, -5.3%

On May 4, 2022, DiaMedica Therapeutics Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.3% in the window around the event. It had already run -6.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$2.62
1d before
$2.48
Event day
$2.55
1d after
$2.57
5d after

Pre-catalyst setup

-6.8%
30-day run-up
5442%
30-day volatility
0.7×
volume spike